The impact of transcriptomics on the fight against tuberculosis: Focus on biomarkers, BCG vaccination, and immunotherapy

Clinical and Developmental Immunology

Volumn 2011, Issue , 2011, Pages

  Passos, Geraldo A ^a,b   Zárate Bladés, Carlos Rodrigo ^a   Silva, Celio Lopes ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Faculty of Dentistry   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DNA HEAT SHOCK PROTEIN 65 VACCINE; DNA VACCINE; HEAT SHOCK PROTEIN 65; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; TUBERCULOSTATIC AGENT;

BCG VACCINATION; CLINICAL RESEARCH; DISEASE MARKER; DRUG EFFICACY; DRUG TREATMENT FAILURE; HEAD AND NECK CARCINOMA; HUMAN; IMMUNOTHERAPY; MYCOBACTERIUM BOVIS; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSCRIPTOMICS; TUBERCULOSIS; ANIMAL; CATTLE; DRUG DEVELOPMENT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METHODOLOGY; MICROARRAY ANALYSIS; PATHOGENICITY; VACCINATION;

ANIMALS; ANTITUBERCULAR AGENTS; BIOLOGICAL MARKERS; CATTLE; DRUG DISCOVERY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNOTHERAPY; MICROARRAY ANALYSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; VACCINATION;

EID: 79251581567     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2011/192630     Document Type: Review

References (58)

1. WHO, Global Tuberculosis Control. A short update to the 2009 report. http://www.who.int/tb/publications/globalreport/2009/en/index.html
2. http://www.stoptb.org/
3. Waddell S. J., Butcher P. D., Microarray analysis of whole genome expression of intracellular Mycobacterium tuberculosis Current Molecular Medicine 2007 7 3 287 296
4. Haller R., Kennedy M., Arnold N., Rutherford R., The transcriptome of Mycobacterium tuberculosis Applied Microbiology and Biotechnology 2010 86 1 1 9
5. Flores-Valdez M. A., Morris R. P., Laval F., Daff M., Schoolnik G. K., Mycobacterium tuberculosis modulates its cell surface via an oligopeptide permease (Opp) transport system FASEB Journal 2009 23 12 4091 4104
6. Bartek I. L., Rutherford R., Gruppo V., Morton R. A., Morris R. P., Klein M. R., Visconti K. C., Ryan G. J., Schoolnik G. K., Lenaerts A., Voskuil M. I., The DosR regulon of M. tuberculosis and antibacterial tolerance Tuberculosis 2009 89 4 310 316
7. MacHugh D. E., Gormley E., Park S. D. E., Browne J. A., Taraktsoglou M., O'Farrelly C., Meade K. G., Gene expression profiling of the host response to Mycobacterium bovis infection in cattle Transboundary and Emerging Diseases 2009 56 6-7 204 214
8. de Kantor I. N., Ambroggi M., Poggi S., Morcillo N., Da Silva Telles M. A., Osrio Ribeirão M., Garzn Torres M. C., LLerena Polo C., Ribn W., Garca V., Kuffo D., Asencios L., Vsquez Campos L. M., Rivas C., de Waard J. H., Human Mycobacterium bovis infection in ten Latin American countries Tuberculosis 2008 88 4 358 365
9. Schnappinger D., Schoolnik G. K., Ehrt S., Expression profiling of host pathogen interactions: how Mycobacterium tuberculosis and the macrophage adapt to one another Microbes and Infection 2006 8 4 1132 1140
10. Chaussabel D., Semnani R. T., McDowell M. A., Sacks D., Sher A., Nutman T. B., Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites Blood 2003 102 2 672 681
11. Mortellaro A., Robinson L., Paola R. C., Spotlight on mycobacteria and dendritic cells: will novel targets to fight tuberculosis emerge? EMBO Molecular Medicine 2009 1 1 19 29
12. Harding C. V., Boom W. H., Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors Nature Reviews Microbiology 2010 8 4 296 307
13. Kendall S. L., Rison S. C. G., Movahedzadeh F., Frita R., Stoker N. G., What do microarrays really tell us about M. tuberculosis ? Trends in Microbiology 2004 12 12 537 544
14. Dheda K., Booth H., Huggett J. F., Johnson M. A., Zumla A., Rook G. A. W., Lung remodeling in pulmonary tuberculosis Journal of Infectious Diseases 2005 192 7 1201 1210
15. Rook G. A. W., Dheda K., Zumla A., Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting? Vaccine 2005 23 17-18 2115 2120
16. Wallis R. S., Pai M., Menzies D., Doherty T. M., Walzl G., Perkins M. D., Zumla A., Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice The Lancet 2010 375 9729 1920 1937
17. Parida S. K., Kaufmann S. H. E., The quest for biomarkers in tuberculosis Drug Discovery Today 2010 15 3-4 148 157
18. Van't Veer L. J., Dai H., Van de Vijver M. J., He Y. D., Hart A. A. M., Mao M., Peterse H. L., Van Der Kooy K., Marton M. J., Witteveen A. T., Schreiber G. J., Kerkhoven R. M., Roberts C., Linsley P. S., Bernards R., Friend S. H., Gene expression profiling predicts clinical outcome of breast cancer Nature 2002 415 6871 530 536
19. Jacobsen M., Repsilber D., Gutschmidt A., Neher A., Feldmann K., Mollenkopf H. J., Ziegler A., Kaufmann S. H. E., Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis Journal of Molecular Medicine 2007 85 6 613 621
20. Mistry R., Cliff J. M., Clayfon C. L., Beyers N., Mohamed Y. S., Wilson P. A., Dockrell H. M., Wallace D. M., Van Helden P. D., Duncan K., Lukey P. T., Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis Journal of Infectious Diseases 2007 195 3 357 365
21. Berry M. P. R., Graham C. M., McNab F. W., Xu Z., Bloch S. A. A., Oni T., Wilkinson K. A., Banchereau R., Skinner J., Wilkinson R. J., Quinn C., Blankenship D., Dhawan R., Cush J. J., Mejias A., Ramilo O., Kon O. M., Pascual V., Banchereau J., Chaussabel D., O'Garra A., An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis Nature 2010 466 7309 973 977
22. Andersen P., Doherty T. M., The success and failure of BCGimplications for a novel tuberculosis vaccine Nature Reviews Microbiology 2005 3 8 656 662
23. Ritz N., Hanekom W. A., Robins-Browne R., Britton W. J., Curtis N., Influence of BCG vaccine strain on the immune response and protection against tuberculosis FEMS Microbiology Reviews 2008 32 5 821 841
24. Behr M. A., Wilson M. A., Gill W. P., Salamon H., Schoolnik G. K., Rane S., Small P. M., Comparative genomics of BCG vaccines by whole-genome DNA microarray Science 1999 284 5419 1520 1523
25. Mollenkopf H. J., Hahnke K., Kaufmann S. H. E., Transcriptional responses in mouse lungs induced by vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosis Microbes and Infection 2006 8 1 136 144
26. Cortes E. A., Kaveh D., Nunez-Garcia J., Hogarth P. J., Martin Vordermeier H., Mycobacterium bovis -BCG vaccination induces specific pulmonary transcriptome biosignatures in mice PLoS One 2010 5 6
27. Wu BO., Huang C., Garcia L., De Leon A. P., Osornio J. S., Bobadilla-del-Valle M., Ferreira L., Canizales S., Small P., Kato-Maeda M., Krensky A. M., Clayberger C., Unique gene expression profiles in infants vaccinated with different strains of Mycobacterium bovis bacille Calmette-Gurin Infection and Immunity 2007 75 7 3658 3664
28. Roth A. E., Stensballe L. G., Garly M. L., Aaby P., Beneficial non-targeted effects of BCG-Ethical implications for the coming introduction of new TB vaccines Tuberculosis 2006 86 6 397 403
29. Sierra V. G., Is a new tuberculosis vaccine necessary and feasible? A Cuban opinion Tuberculosis 2006 86 3-4 169 178
30. Ma Z., Lienhardt C., McIlleron H., Nunn A. J., Wang X., Global tuberculosis drug development pipeline: the need and the reality The Lancet 2010 375 9731 2100 2109
31. Rook G. A. W., Lowrie D. B., Hernndez-Pando R., Immunotherapeutics for tuberculosis in experimental animals: is there a common pathway activated by effective protocols? Journal of Infectious Diseases 2007 196 2 191 198
32. Cardona P. J., New insights on the nature of latent tuberculosis infection and its treatment Inflammation and Allergy: Drug Targets 2007 6 1 27 39
33. Stanford J., Stanford C., Grange J., Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis Frontiers in Bioscience 2004 9 1701 1719
34. Dlugovitzky D., Notario R., Martinel-Lamas D., Fiorenza G., Farroni M., Bogue C., Stanford C., Stanford J., Immunotherapy with oral, heat-killed, Mycobacterium vaccae in patients with moderate to advanced pulmonary tuberculosis Immunotherapy 2010 2 2 159 169
35. Vilaplana C., Montan E., Pinto S., Barriocanal A. M., Domenech G., Torres F., Cardona P. J., Costa J., Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI Vaccine 2010 28 4 1106 1116
36. Silva C. L., Palacios A., Colston M. J., Lowrie D. B., Mycobacterium leprae 65hsp antigen expressed from a retroviral vector in a macrophage cell line is presented to T cells in association with MHC class II in addition to MHC class I Microbial Pathogenesis 1992 12 1 27 38
37. Silva C. L., Lowrie D. B., A single mycobacterial protein (hsp 65) expressed by a transgenic antigen- presenting cell vaccinates mice against tuberculosis Immunology 1994 82 2 244 248
38. Gonalves E. D. C., Bonato V. L., da Fonseca D. M., Soares E. G., Brando I. T., Soares A. P. M., Silva C. L., Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming Genetic Vaccines and Therapy 2007 5, article no. 7
39. Souza P. R. M., Zrate-Blads C. R., Hori J. I., Ramos S. G., Lima D. S., Schneider T., Rosada R. S., Torre L. G. L., Santana M. H. A., Brando I. T., Masson A. P., Coelho-Castelo A. A. M., Bonato V. L., Galetti F. C. S., Gonalves E. D., Botte D. A., Machado J. B. M., Silva C. L., Protective efficacy of different strategies employing Mycobacterium leprae heat-shock protein 65 against tuberculosis Expert Opinion on Biological Therapy 2008 8 9 1255 1264
40. Rosada R. S., de la Torre L. G., Frantz F. G., Trombone A. P. F., Zrate-Blads C. R., Fonseca D. M., Souza P. R. M., Brando I. T., Masson A. P., Soares. G., Ramos S. G., Faccioli L. H., Silva C. L., Santana M. H. A., Coelho-Castelo A. A. M., Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes BMC Immunology 2008 9, article no. 38
41. Lukacs K. V., Lowrie D. B., Stokes R. W., Colston M. J., Tumor cells transfected with a bacterial heat-shock gene lose tumorigenicity and induce protection against tumors Journal of Experimental Medicine 1993 178 1 343 348
42. Xu J., Zhu Z., Wu J., Liu W., Shen X., Zhang Y., Hu Z., Zhu D., Roque R. S., Liu J., Immunization with a recombinant GnRH vaccine conjugated to heat shock protein 65 inhibits tumor growth in orthotopic prostate cancer mouse model Cancer Letters 2008 259 2 240 250
43. Xiangbing HU., Yankai Z., Ming L., Yong LU., Yu Z., Huiyong Z., Yingying C., Jing H., Yun X., Liang J., Rongyue C., Jingjing L., The fusion protein of HSP65 with tandem repeats of -hCG acting as a potent tumor vaccine in suppressing hepatocarcinoma International Immunopharmacology 2010 10 2 230 238
44. Michaluart P., Abdallah K. A., Lima F. D., Smith R., Moyss R. A., Coelho V., Victora G. D., Socorro-Silva A., Volsi E. C., Zrate-Blads C. R., Ferraz A. R., Barreto A. K., Chammas M. C., Gomes R., Gebrim E., Arakawa-Sugueno L., Fernandes K. P., Lotufo P. A., Cardoso M. R., Kalil J., Silva C. L., Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck Cancer Gene Therapy 2008 15 10 676 684
45. Victora G. D., Socorro-Silva A., Volsi E. C., Abdallah K., Lima F. D., Smith R. B., Moyses R. A., Zrate-Blads C. R., Michaluart P., Silva C. L., Kalil J., Coelho V., Immune response to vaccination with DNA-hsp65 in a phase i clinical trial with head and neck cancer patients Cancer Gene Therapy 2009 16 7 598 608
46. Lowrie D. B., Tascon R. E., Bonato V. L. D., Lima V. M. F., Faccoli L. H., Stavropoulos E., Colston M. J., Hewinson R. G., Moelling K., Silva C. L., Therapy of tuberculosis in mice by DNA vaccination Nature 1999 400 6741 269 271
47. Lowrie D. B., Silva C. L., Enhancement of immunocompetence in tuberculosis by DNA vaccination Vaccine 2000 18 16 1712 1716
48. Silva C. L., Bonato V. L. D., Coelho-Castelo A. A. M., De Souza A. O., Santos S. A., Lima K. M., Faccioli L. H., Rodrigues J. M., Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice Gene Therapy 2005 12 3 281 287
49. Lowrie D. B., DNA vaccines for therapy of tuberculosis: where are we now? Vaccine 2006 24 12 1983 1989
50. Zrate-Blads C. R., Bonato V. L. D., da Silveira E. L. V., Oliveira e Paula M., Junta C. M., Sandrin-Garcia P., Fachin A. L., Mello S. S., Cardoso R. S., Galetti F. C. DE. S., Coelho-Castelo A. A. M., Ramos S. G., Donadi E. A., Sakamoto-Hojo E. T., Passos G. A. DA. S., Silva C. L., Comprehensive gene expression profiling in lungs of mice infected with Mycobacterium tuberculosis following DNAhsp65 immunotherapy Journal of Gene Medicine 2009 11 1 66 78
51. Reddy T. B. K., Riley R., Wymore F., Montgomery P., Decaprio D., Engels R., Gellesch M., Hubble J., Jen D., Jin H., Koehrsen M., Larson L., Mao M., Nitzberg M., Sisk P., Stolte C., Weiner B., White J., Zachariah Z. K., Sherlock G., Galagan J. E., Ball C. A., Schoolnik G. K., TB database: an integrated platform for tuberculosis research Nucleic Acids Research 2009 37 1 D499 D508
52. Galagan J. E., Sisk P., Stolte C., Weiner B., Koehrsen M., Wymore F., Reddy T. B. K., Engels R., Gellesch M., Hubble J., Jin H., Larson L., Mao M., Nitzberg M., White J., Zachariah Z. K., Sherlock G., Ball C. A., Schoolnik G. K., TB database 2010: overview and update Tuberculosis 2010 90 4 225 235
53. Gaucher D., Therrien R., Kettaf N., Angermann B. R., Boucher G., Filali-Mouhim A., Moser J. M., Mehta R. S., Drake D. R., Castro E., Akondy R., Rinfret A., Yassine-Diab B., Said E. A., Chouikh Y., Cameron M. J., Clum R., Kelvin D., Somogyi R., Greller L. D., Balderas R. S., Wilkinson P., Pantaleo G., Tartaglia J., Haddad E. K., Sekaly R. P., Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses Journal of Experimental Medicine 2008 205 13 3119 3131
54. Querec T. D., Akondy R. S., Lee E. K., Cao W., Nakaya H. I., Teuwen D., Pirani A., Gernert K., Deng J., Marzolf B., Kennedy K., Wu H., Bennouna S., Oluoch H., Miller J., Vencio R. Z., Mulligan M., Aderem A., Ahmed R., Pulendran B., Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans Nature Immunology 2009 10 1 116 125
55. Monath T. P., Yellow fever vaccine Expert Review of Vaccines 2005 4 4 553 574
56. Pulendran B., Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology Nature Reviews Immunology 2009 9 10 741 747
57. Young D., Stark J., Kirschner D., Systems biology of persistent infection: tuberculosis as a case study Nature Reviews Microbiology 2008 6 7 520 528
58. Comas I., Gagneux S., The past and future of tuberculosis research PLoS Pathogens 2009 5 10